Matching articles for "Durolane"

Two New Intra-Articular Injections for Knee Osteoarthritis

   
The Medical Letter on Drugs and Therapeutics • August 27, 2018;  (Issue 1554)
The FDA has approved a single-injection hyaluronic acid gel (Durolane – Bioventus) and an extended-release (ER) formulation of the synthetic corticosteroid triamcinolone acetonide (Zilretta – Flexion)...
The FDA has approved a single-injection hyaluronic acid gel (Durolane – Bioventus) and an extended-release (ER) formulation of the synthetic corticosteroid triamcinolone acetonide (Zilretta – Flexion) for intra-articular (IA) treatment of osteoarthritic knee pain.
Med Lett Drugs Ther. 2018 Aug 27;60(1554):142-4 | Show Full IntroductionHide Full Introduction